Iperoxo
CAS No. 247079-84-1
Iperoxo( Iperoxo iodide )
Catalog No. M27817 CAS No. 247079-84-1
Iperoxo, an OxotremorineM analog, is a muscarinic acetylcholine receptors superagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 113 | In Stock |
|
| 5MG | 103 | In Stock |
|
| 10MG | 168 | In Stock |
|
| 25MG | 339 | In Stock |
|
| 50MG | 500 | In Stock |
|
| 100MG | 733 | In Stock |
|
| 200MG | 1004 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIperoxo
-
NoteResearch use only, not for human use.
-
Brief DescriptionIperoxo, an OxotremorineM analog, is a muscarinic acetylcholine receptors superagonist.
-
DescriptionIperoxo, an OxotremorineM analog, is a muscarinic acetylcholine receptors superagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsIperoxo iodide
-
PathwayOthers
-
TargetOther Targets
-
RecptorAndrogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number247079-84-1
-
Formula Weight182.223
-
Molecular FormulaC9H14N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (192.81 mM)
-
SMILESCN(C)CC#CCOC1=NOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CYP11B2-IN-1
CYP11B2-IN-1 is a CYP11B2 inhibitor with IC50 of 2.3 nM. CYP11B2-IN-1 inhibits CYP11B1 with IC50 of 142 nM.
-
3-(2-Glucosyloxy-4-m...
2-O-beta-d-Glucosyloxy-4-methoxybenzenepropanoic acid[3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid] exhibits glutathione S-transferase (GST) inhibitory and antifungal activities.
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
Cart
sales@molnova.com